Accelerometer-Based Activity Sensing by an Insertable Cardiac Monitor In Ambulatory Patients: A Subanalysis of LUX-Dx TRENDS (LUX-Dx Heart Failure Sensors in an Insertable Cardiac Monitor System Clinical Study) - Summary - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Activity Monitoring With an Insertable Cardiac Monitor in Ambulatory Patients: Subanalysis of the LUX-Dx TRENDS Clinical Study of Heart Failure Sensors

  • By

  • ANDREW J. SAUER

  • E. MATTHEW QUIN

  • KARAN BHALLA

  • SASHI ADIGOPULA

  • BIN MI

  • EMILY THOMPSON

  • DEEPA MAHAJAN

  • MING DUANMU

  • CRAIG M. STOLEN

  • MOLLY E. KUPFER

  • ALYSIA ROSNER

  • SELÇUK ADABAG

  • SCOTT D. SOLOMON

  • ELAINE Y. WAN

  • October 11, 2026

Share

Objective:

To assess the relationship between subcutaneous accelerometer signals and treadmill walking speed and evaluate an insertable cardiac monitor (ICM) algorithm for classifying activity.

Approach:
  • Study population: Exercise-substudy participants are adults with New York Heart Association class II or III heart failure enrolled in the multicenter LUX-Dx TRENDS study who are considered suitable for exercise testing.
  • Assessments: Participants maintain stationary postures and complete progressively faster treadmill stages. Investigators analyze accelerometer signals and compare algorithm classifications with a prespecified reference standard.
  • Analysis: The primary classification analysis defines walking speeds ≥1.2 mph as active and stationary postures as inactive, excluding the 0.7-mph treadmill stage. Agreement is assessed in dataset 2 using Cohen’s kappa.
Key Findings:
  • The exercise substudy includes 104 participants at 26 US sites; device data are analyzed for 56 participants in dataset 1 and 45 in dataset 2. Device data are unavailable for 3 participants.
  • Activity signals increase by an estimated 33.7 mG per 1-mph increase in walking speed in dataset 1 and 32.3 mG in dataset 2; both associations have P < .0001.
  • In dataset 2, agreement between algorithm classifications and the reference standard is κ = 0.971 (95% CI, 0.947–0.985), exceeding the prespecified goal of κ > 0.8.
  • Sensitivity is 0.974, specificity is 0.994, positive predictive value is 0.991, and negative predictive value is 0.982.
  • The kappa performance goal remains met in sensitivity analyses classifying the 0.7-mph treadmill stage as either active or inactive.
Interpretation:

In this ambulatory heart failure population, subcutaneous accelerometer signals show a strong positive association with treadmill walking speed, and the device algorithm shows high agreement with the prespecified activity reference standard under controlled conditions.

Limitations:
  • Testing is limited to controlled treadmill exercise and stationary postures; other activities, including biking and swimming, are not studied.
  • Gait differences, treadmill calibration, operator compliance, reference-label inaccuracies, and external vibration may affect results. Several potential influences, including electromagnetic interference, temperature variation, and respiratory rate changes, are not assessed.
  • Stationary measurements may not reflect prolonged rest during sleep. Selection may exclude frailer or gait-limited patients, and substantial attrition occurs at higher speeds. Algorithm performance is not evaluated within patient subgroups.
Conclusion:

The findings demonstrate the feasibility of accelerometer-based activity assessment using a miniaturized subcutaneous ICM. Further research should evaluate the algorithm’s real-world utility for detection, risk stratification, and patient management.

Sources:

Original Source(s)

Related Content